Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

Trevor A. Crowell, Donn J. Colby, Suteeraporn Pinyakorn, Carlo Sacdalan, Amélie Pagliuzza, Jintana Intasan, Khunthalee Benjapornpong, Kamonkan Tangnaree, Nitiya Chomchey, Eugène Kroon, Mark S. de Souza, Sodsai Tovanabutra, Morgane Rolland, Michael A. Eller, Dominic Paquin-Proulx, Diane L. Bolton, Andrey Tokarev, Rasmi Thomas, Hiroshi Takata, Lydie TrautmannShelly J. Krebs, Kayvon Modjarrad, Adrian B. McDermott, Robert T. Bailer, Nicole Doria-Rose, Bijal Patel, Robert J. Gorelick, Brandie A. Fullmer, Alexandra Schuetz, Pornsuk V. Grandin, Robert J. O'Connell, Julie E. Ledgerwood, Barney S. Graham, Randall Tressler, John R. Mascola, Nicolas Chomont, Nelson L. Michael, Merlin L. Robb, Nittaya Phanuphak, Jintanat Ananworanich, Julie A. Ake, Siriwat Akapirat, Meera Bose, Evan Cale, Phillip Chan, Sararut Chanthaburanun, Nampueng Churikanont, Peter Dawson, Netsiri Dumrongpisutikul, Saowanit Getchalarat, Surat Jongrakthaitae, Krisada Jongsakul, Sukalaya Lerdlum, Sopark Manasnayakorn, Corinne McCullough, Mark Milazzo, Bessara Nuntapinit, Kier On, Madelaine Ouellette, Praphan Phanuphak, Eric Sanders-Buell, Nongluck Sangnoi, Shida Shangguan, Sunee Sirivichayakul, Nipattra Tragonlugsana, Rapee Trichavaroj, Sasiwimol Ubolyam, Sandhya Vasan, Phandee Wattanaboonyongcharoen, Thipvadee Yamchuenpong

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences